Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
All data referred to in this reply is available as described in the original Tractor publication4.
Popejoy, A. B. & Fullerton, S. M. Genomics is failing on diversity. Nature 538, 161–164 (2016).
Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diversity in human genetic studies. Cell 177, 1080 (2019).
Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584–591 (2019).
Atkinson, E. G. et al. Tractor uses local ancestry to enable the inclusion of admixed individuals in GWAS and to boost power. Nat. Genet. 53, 195–204 (2021).
Wang, Y. et al. Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations. Nat. Commun. 11, 3865 (2020).
Bergström, A. et al. Insights into human genetic variation and population history from 929 diverse genomes. Science 367, eaay5012 (2020).
1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
Skotte, L., Jørsboe, E., Korneliussen, T. S., Moltke, I. & Albrechtsen, A. Ancestry-specific association mapping in admixed populations. Genet. Epidemiol. 43, 506–521 (2019).
Broekema, R. V., Bakker, O. B. & Jonkers, I. H. A practical view of fine-mapping and gene prioritization in the post-genome-wide association era. Open Biol. 10, 190221 (2020).
MacArthur, D. G. et al. Guidelines for investigating causality of sequence variants in human disease. Nature 508, 469–476 (2014).
Schaid, D. J., Chen, W. & Larson, N. B. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat. Rev. Genet. 19, 491–504 (2018).
M.J.D. is a founder of Maze Therapeutics. B.M.N. is a member of the Deep Genomics Scientific Advisory Board and serves as a consultant for the Camp4 Therapeutics Corporation, Takeda Pharmaceutical and Biogen. The remaining authors declare no competing interests.
Peer review information Nature Genetics thanks Loïc Yengo and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Atkinson, E.G., Bloemendal, A., Maihofer, A.X. et al. Reply to: On powerful GWAS in admixed populations. Nat Genet (2021). https://doi.org/10.1038/s41588-021-00975-z